Modulation of Krüppel-like factors (KLFs) interaction with their binding partners in cancers through acetylation and phosphorylation
- PMID: 37992989
- DOI: 10.1016/j.bbagrm.2023.195003
Modulation of Krüppel-like factors (KLFs) interaction with their binding partners in cancers through acetylation and phosphorylation
Abstract
Post-translational modifications (PTMs) of transcription factors regulate transcriptional activity and play a key role in essentially all biological processes and generate indispensable insight towards biological function including activity state, subcellular localization, protein solubility, protein folding, substrate trafficking, and protein-protein interactions. Amino acids modified chemically via PTMs, function as molecular switches and affect the protein function and characterization and increase the proteome complexity. Krüppel-like transcription factors (KLFs) control essential cellular processes including proliferation, differentiation, migration, programmed cell death and various cancer-relevant processes. We investigated the interactions of KLF group-2 members with their binding partners to assess the role of acetylation and phosphorylation in KLFs on their binding affinity. It was observed that acetylation and phosphorylation at different positions in KLFs have a variable effect on binding with specific partners. KLF2-EP300, KLF4-SP1, KLF6-ATF3, KLF6-JUN, and KLF7-JUN show stabilization upon acetylation or phosphorylation at variable positions. On the other hand, KLF4-CBP, KLF4-EP300, KLF5-CBP, KLF5-WWP1, KLF6-SP1, and KLF7-ATF3 show stabilization or destabilization due to acetylation or phosphorylation at variable positions in KLFs. This provides a molecular explanation of the experimentally observed dual role of KLF group-2 members as a suppressor or activator of cancers in a PTM-dependent manner.
Keywords: Acetylation; Cancer; Krüppel-like transcription factors (KLFs); Phosphorylation; Post-translational modification (PTM).
Copyright © 2023. Published by Elsevier B.V.
Conflict of interest statement
Declaration of competing interest The authors declare no competing interest.
Similar articles
-
The kruppel-like factor (KLF) family, diseases, and physiological events.Gene. 2024 Feb 15;895:148027. doi: 10.1016/j.gene.2023.148027. Epub 2023 Nov 23. Gene. 2024. PMID: 38000704 Review.
-
The emerging role of Krüppel-like factors in endocrine-responsive cancers of female reproductive tissues.J Endocrinol. 2010 Mar;204(3):223-31. doi: 10.1677/JOE-09-0329. Epub 2009 Oct 15. J Endocrinol. 2010. PMID: 19833720 Free PMC article. Review.
-
Cell and tissue specific expression of human Krüppel-like transcription factors in human ocular surface.Mol Vis. 2004 Nov 23;10:901-9. Mol Vis. 2004. PMID: 15570219
-
[Research progress on the roles of Krüppel-like factors in muscle tissues].Yi Chuan. 2018 Sep 20;40(9):733-748. doi: 10.16288/j.yczz.18-095. Yi Chuan. 2018. PMID: 30369477 Review. Chinese.
-
Pharmacological and toxicological roles of Kruppel-like factors (KLFs) in the cardiovascular system: a review.Mol Biol Rep. 2025 May 26;52(1):506. doi: 10.1007/s11033-025-10613-0. Mol Biol Rep. 2025. PMID: 40418318 Review.
Cited by
-
Role of post-translational modifications of Sp1 in cancer: state of the art.Front Cell Dev Biol. 2024 Aug 20;12:1412461. doi: 10.3389/fcell.2024.1412461. eCollection 2024. Front Cell Dev Biol. 2024. PMID: 39228402 Free PMC article. Review.
-
KLF4: a multifunctional nexus connecting tumor progression and immune regulation.Front Immunol. 2025 Feb 6;16:1514780. doi: 10.3389/fimmu.2025.1514780. eCollection 2025. Front Immunol. 2025. PMID: 39995670 Free PMC article. Review.
-
Kruppel-like factor 9 may regulate the inflammatory injury of chondrocytes by affecting NF-κB signaling.J Orthop Surg Res. 2025 Jun 18;20(1):599. doi: 10.1186/s13018-025-05974-y. J Orthop Surg Res. 2025. PMID: 40533763 Free PMC article.
-
Alterations of Krüppel-like Factor Signaling and Potential Targeted Therapy for Hepatocellular Carcinoma.Anticancer Agents Med Chem. 2025;25(2):75-85. doi: 10.2174/0118715206301453240910044913. Anticancer Agents Med Chem. 2025. PMID: 39313900 Review.
-
Engineered Mesenchymal Stem Cell-Derived Small Extracellular Vesicles Mitigate Liver Fibrosis by Delivering USP10 to Reprogram Macrophage Phenotype.Biomater Res. 2025 Aug 26;29:0244. doi: 10.34133/bmr.0244. eCollection 2025. Biomater Res. 2025. PMID: 40873954 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous